MITS Fund
VC Fund
Los Altos, United States
MITS Fund is a VC fund in Los Altos focused on Software and Apps. MITS Fund - or 'Machine In The Sky' Fund - is a multi-stage investment fund looking to back inspiring entrepreneurs in building world-changing companies. MITS Fund operates primarily in the San Francisco Bay Area, but makes investments globally. Although not explicitly, MITS Fund prefers investments that have a double bottom line.
- Total investments:
- 6
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries MITS Fund invests in
Stages MITS Fund invests in
Countries MITS Fund invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Investment Focus
Industry
- Software 3 (50%)
- Apps 1 (17%)
- SaaS 1 (17%)
- EdTech 1 (17%)
- FinTech 1 (17%)
Stage
- Seed 2 (33%)
- Series A 2 (33%)
- Convertible Note 1 (17%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Shawn Byers
Founder and Managing Partner
|
Founder and Managing Partner | Total investments: 5 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Atlas provides mobile banking online. James Schuler and Mickey Costa founded it in 2014, with its headquarters in Malibu in California. | $1M / Seed / Jan 11, 2018 | ||
| Atlas provides mobile banking online. James Schuler and Mickey Costa founded it in 2014, with its headquarters in Malibu in California. | $1.9M / Seed / Dec 31, 2015 | ||
| Seeds transforms the world through mobile apps. They give app developers the tools to create in-app purchases that help people in need - through microloans! They aim to create a bigger pie for all to grow business, increase customer satisfaction, and help those in need. | $800K / Convertible Note / Dec 25, 2015 | ||
| Strateos automates chemistry, biology, and tissue analysis into closed-loop robotic labs that accelerate drug discovery programs. Through a combination of best-in-class robotics and control systems, advanced software for imaging and analytics, and remote cloud laboratories, they enable pharmaceutical partners to more rapidly and efficientlydiscover new drug candidates.Born of a merger between Transcriptic and 3Scan, Strateos combines the strengths of those companies to amplify their impact and accelerate drug discovery. Transcriptic developed the first robotic cloud laboratory platform for on-demand life science research, which is currently in use at several top pharmaceutical and biotechnology companies. 3Scan combined automation, machine learning and computer vision to extract spatial data from tissue samples and create detailed 3D representations as well as quantitative analysis of complex anatomical structures. Now these two portfolios will be combined to offer a suite of technologies for accelerating drug discovery and early development.By expressing life science methods as data, infrastructure virtualization will become possible. "Science-as-a-Service" will power the next generation of discovery, driven by huge efficiencies of both time and money.Transcriptic was founded in 2012 to create a better way to get lab work done. Tired of spending endless hours at the bench pretending to be slow, error-prone robots, they set out to build a modern solution to the day-to-day process of wet lab biology.Drawing on deep computer science and electrical engineering backgrounds in addition to life science, Strateos was born: a meticulously optimized, technology-enabled remote lab. Using state-of-the-art automation and control technology, and an emphasis on user experience and usability, they are working on building a stark contrast to the long, complicated sales process, high prices, and slow turnarounds of traditional CROs.They are working hard to build a great company that can be a true partner for your lab for a long time, progressively enabling ever greater levels of productivity and efficiency. They are scientists building for scientists. | $8.5M / Series A / Feb 19, 2015 | ||
| Newsela is an Edtech startup that takes real and new content from trusted providers and turns it into learning materials. | $6M / Series A / Sep 24, 2014 | ||
| Funnely helps online stores' owners create and optimize their Facebook Ads campaigns with a conversion oriented strategy. Through our platform small and medium online sellers grow their audience, improve their online Ads performance and increase their sales. | $988K / Seed / Aug 10, 2014 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does MITS Fund invest in?
MITS Fund invests primarily in Software, Apps and SaaS startups, most often at Seed and Series A stage. Most of the 6 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact MITS Fund?
Public channels for MITS Fund include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at MITS Fund?
The team at MITS Fund includes Shawn Byers (Founder and Managing Partner). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
